GERM-LINE GENE THERAPY "WORTH THE RISK," KENNEDY ETHICS INSTITUTE DIRECTOR TELLS CONFERENCE; THERAPY WILL NOT STAY NARROWLY CONTAINED, ATTORNEY WARNS
Executive Summary
The potential benefits of germ-line gene therapy justify "bold action" in developing the technique and are "worth the risk" despite ethics concerns, Kennedy Ethics Institute Director Robert Veatch, Georgetown University, maintained at a City of Hope conference on genetic ethics May 23 in Pasadena, Calif.